This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louie, M.
Right arrow Articles by Simor, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louie, M.
Right arrow Articles by Simor, A. E.
Related Collections
Right arrow Other infectious diseases
Right arrow Molecular Medicine
Right arrow Laboratory Medicine - see also Molecular Medicine
CMAJ • August 8, 2000; 163 (3)
© 2000 Canadian Medical Association or its licensors

Review
Synthèse

The role of DNA amplification technology in the diagnosis of infectious diseases

Marie Louie*{dagger}, Lisa Louie* and Andrew E. Simor*{dagger}

From *the Department of Microbiology, SD Laboratory Services and the Division of Infectious Diseases, Sunnybrook & Women's College Health Sciences Centre, and {dagger}the Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ont.

Abstract

NUCLEIC ACID AMPLIFICATION AND DETECTION METHODS developed in the past decade are useful for the diagnosis and management of a variety of infectious diseases. The most widely used of these methods is the polymerase chain reaction (PCR). PCR assays can detect rapidly and accurately the presence of fastidious and slow-growing microorganisms, such as Chlamydia, mycoplasmas, mycobacteria, herpesviruses and enteroviruses, directly from clinical specimens. Commercial PCR assays for the diagnosis of tuberculosis and genital C. trachomatis infection are now routinely used in many diagnostic laboratories. Assays have also been developed that can detect antimicrobial resistance and are used to identify the cause of infection by organisms that cannot be cultivated. The value of viral load measurement by nucleic acid amplification in the management of patients with HIV infection or hepatitis C has also been well established. However, evaluations of this technology for rapid microbial diagnosis have generally been limited by small samples, and the cost of these assays may be as high as Can$125 per test. As nucleic acid amplification methods continue to evolve, their role in the diagnosis and management of patients with infectious diseases and their impact on clinical outcomes will become better defined.




This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
L. R. Peterson and A. Dalhoff
Towards targeted prescribing: will the cure for antimicrobial resistance be specific, directed therapy through improved diagnostic testing?
J. Antimicrob. Chemother., June 1, 2004; 53(6): 902 - 905.
[Abstract] [Full Text] [PDF]

Home page
 Sex. Transm. Infect.Home page
V Verhoeven, M Ieven, A Meheus, D Avonts, and H Goossens
First, do not harm: also an issue in NAA assay diagnostics for chlamydial infection
Sex Transm Inf, February 1, 2003; 79(1): 76 - 77.
[Full Text] [PDF]

Home page
 CMAJHome page
A. Sinclair
Genetics 101: polymerase chain reaction
Can. Med. Assoc. J., October 29, 2002; 167(9): 1032 - 1033.
[Full Text] [PDF]

Home page
 CMAJHome page
A. Sinclair and J. Hall
The very youngest science
Can. Med. Assoc. J., August 1, 2002; 167(3): 253 - 254.
[Full Text] [PDF]

Home page
 Br J OphthalmolHome page
P A Gaudio, U Gopinathan, V Sangwan, and T E Hughes
Polymerase chain reaction based detection of fungi in infected corneas
Br J Ophthalmol, July 1, 2002; 86(7): 755 - 760.
[Abstract] [Full Text] [PDF]